Retrospective Comparison of the Dosimetric Parameters of Brachytherapy and Sbrt Plans in Cervical Cancer

Year 2021, Volume: 47 Issue: 3, 381 - 387, 01.12.2021

Metin Zorlutuna , Candan Demiröz Abakay , Hidayetül Mediha Kılıç , Mehmet Tosun , Meral Kurt , Sibel Kahraman Çetintaş , Süreyya Sarıhan , Ali Altay

https://doi.org/10.32708/uutfd.1011447

Abstract

Archival material belonging to 15 patients diagnosed with cervical cancer who were treated at Bursa Uludağ University Faculty of Medicine, Department of Radiation Oncology were obtained. Brachytherapy and SBRT plans were created and compared. The data were transferred to Accuray Precision TPS, the planned target volume (PTV) and critical organs (bladder, rectum, sigmoid colon, bone marrow) were contoured to create retrospective plans. The total dose prescribed for all patients was 21 Gy, given in 3 fractions. Dose distributions were obtained with the DVHs in the created virtual plans. It was aimed to compare critical organ (bladder, rectum, sigmoid colon and bone marrow) doses and EQD2 and BED values. There was a significant difference between the treatment techniques in favor of the SBRT technique for bladder D0.10cc values. A significant difference was found in favor of the SBRT technique for the D50.00cc, D75.00cc and D100.00cc values of the bone marrow. A positive significant difference was found in favor of SBRT for D0.10cc in terms of EQD2 and BED values (α/β=3) and (α/β=10) of the bladder. A significant difference was found in favor of SBRT in terms of EQD2 and BED values of bone marrow (α/β=3) and (α/β=10) for D50.00cc, D75.00cc and D100.00cc. As a result; SBRT can be used as a good alternative in cases where BRT, which is seen as the standard treatment after EBRT, is not feasible.

Keywords

BRACHYTHERAPY, CERVICAL CANCER, SBRT, Cyberknife

Serviks Kanserinde Brakiterapi ve SBRT Planlarının Dozimetrik Parametrelerinin Retrospektif Olarak Karşılaştırılması

Abstract

Bursa Uludağ Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalı’nda tedavi almış serviks kanseri tanılı 15 hastaya ait arşiv materyali elde edildi. Brakiterapi ve SBRT planları oluşturularak karşılaştırıldı. Veriler Accuray Precision TPS’ye aktarılmış, retrospektif planların oluşturulması için planlanan hedef hacim (PTV) ve kritik organlar (mesane, rektum, sigmoid kolon, kemik iliği) konturlandı. Tüm hastalar için reçete edilen toplam doz 21 Gy, 3 fraksiyonda verildi. Oluşturulan sanal planlardaki DVH’ler ile doz dağılımları elde edildi. Kritik organ (mesane, rectum, sigmoid kolon ve kemik iliği) dozları ve EQD2 ve BED değerlerinin karsılaştırılması amaçlandı. Tedavi teknikleri arasında mesanenin D0,10cc değerleri için SBRT tekniği lehine anlamlı fark bulundu. Kemik iliğinin D50,00cc, D75,00cc ve D100,00cc değerleri için SBRT tekniği lehine anlamlı fark bulundu. Mesanenin EQD2 ve BED değerleri (α/β=3) ve (α/β=10) açısından D0,10cc için SBRT lehine olumlu yönde anlamlı farklılık bulundu. Kemik iliğinin EQD2 ve BED değerleri (α/β=3) ve (α/β=10) açısından D50,00cc, D75,00cc ve D100,00cc için SBRT lehine anlamlı farklılık bulundu. Sonuç olarak; SBRT, EBRT sonrası standart tedavi olarak görülen BRT’nin uygulanabilir olmadığı durumlarda iyi bir alternatif olarak kullanılabilir.

Keywords

BRAKİTERAPİ, SERVİKS KANSERİ, SBRT, Cyberknife

References

• 1. Li, Z., Chen, J., Zhao, S., Li, Y., Zhou, J., Liang, J., & Tang, H. (2021). Discovery and validation of novel biomarkers for detection of cervical cancer. Cancer Medicine, January, 1–12.
• 2. Peng, N. J., Hu, C., Chiu, Y. L., Yu, C. C., Li, C. J., et all., (2020). Detection of recurrent cervical cancer and prediction of its patient survival with serum squamous-cell carcinoma-antigen and 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography. Diagnostics, 10(9). 3. Diorgu, F., & Steen, M. (2016). Women ’ s Health and Wellness ClinMed International Library. d(January), 30–33.
• 3. YETMEN, Ö., AKTAŞ, C., & BAKKAL, B. H. (2012). Serviks kanserinde radyoterapi tedavisinin yeri ve önemi. Ankara Sa, 035–040.
• 4. Diorgu, F., & Steen, M. (2016). Women ’ s Health and Wellness ClinMed International Library. d(January), 30–33. https://www.researchgate.net/profile/Robert_Reid19/publication/306373049_International_Journal_of_Women’s_Health_and_Wellness_A_Pragmatic_Approach_to_Hormonal_Testing_in_the_Assessment_of_Disorders_of_Female_Reproduction/links/57bb1ed308aefea8f0f44b3a.pdf
• 5. Kirkbride, P., & Cooper, T. (2011). Stereotactic Body Radiotherapy. Guidelines for Commissioners, Providers and Clinicians: A National Report. Clinical Oncology, 23(3), 163–164. https://doi.org/10.1016/j.clon.2011.01.155
• 6. Cengiz, M., Dogan, A., Ozyigit, G., Erturk, E., Yildiz, F., ve ark., (2012). Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer., Department of Radiation Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Brachytherapy, 11(2), 125–129.
• 7. Higginson, D. S., Morris, D. E., Jones, E. L., Clarke-Pearson, D., & Varia, M. A. (2011). Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology., Department of Radiation Oncology, University of North Carolina at Chapel Hill, 101 Manning Drive, Chapel Hill, NC 27514, USA., Gynecologic Oncology, 120(3), 404–412.
• 8. Göksel, Evren. Ozan., (2017). Stereotaktik vücut radyoterapisi brakiterapinin yerini alabilir mi? ., Acıbadem Kozyatağı Hastanesi, Radyasyon Onkolojisi Kliniği, İstanbul., Turk Onkoloji Dergisi, TURKISH JOURNAL of ONCOLOGY Turk J Oncol 2017;32(Supp 1):53-58
• 9. Mahioğlu, Ş. İ. (2016). Lokal İleri Serviks Kanseri Brakiterapisinde Üç Boyutlu Tedavi ile Stereotaktik Beden Radyoterapisinin Dozimetrik Karşılaştırılması., (İstanbul Üniversitesi. Sağlık. Bilimleri. Enstitüsü)., Yüksek Lisans Tezi. Erişim Adresi: Ulusal Tez Merkezi | Anasayfa (yok.gov.tr)
• 10. Demiral S.(Gülhane Askeri Tıp Akademisi). (2011). Jinekolojik Tümörlerde Stereotaktik Beden Radyoterapi (SBRT )’ li Boost ve Ir-192 Brakiterapi Boost Tedavilerinin Jinekolojik Tümörlerde Stereotaktik Beden Radyoterapi ( SBRT )’ li Boost ve Ir Brakiterapi Boost ve Ir-192 Brakiterapi Boost Tedavilerinin Et. Uzmanlık Tezi.
• 11. Otahal, B., Dolezel, M., Cvek, J., Simetka, O., Klat, J., Knybel, L., Molenda, L., Skacelikova, E., Hlavka, A., & Feltl, D. (2014). Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: A virtual brachytherapy study. Reports of Practical Oncology and Radiotherapy, 19(6), 399–404.
• 12. Nadir Küçük, Esra Küçükmorkoç, Emre Şanlı, S. Ç., Hande Sertkaya Yaman, Doğu Canoğlu, ve ark., & Merkezi), (Özel Anadolu Sağlık. (2020). Serviks Kanserinde Brakiterapi Yerine Stereotaktik Beden Radyoterapisi; Dozimetrik Çalışma.
• 13. Morgenthaler, J., Köhler, C., Budach, V., Sehouli, J., Stromberger, C., Besserer, A., Trommer, M., Baues, C., & Marnitz, S. (2020). Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer. Strahlentherapie Und Onkologie.
• 14. Tumati, V., Dubas, J., Pompos, A., Abdulrahman, R., Timmerman, R., & Albuquerque, K. (2012). Stereotactic Body Radiation Therapy (SBRT) Can Be Dosimetrically Equivalent to High-dose Brachytherapy as a Boost for Locally Advanced Cervical Cancer— A New Clinical Trial Concept. International Journal of Radiation Oncology*Biology*Physics, 84(3), S428.
• 15. Lee, T. H., Song, C., Kim, I. A., Kim, J.-S., Kim, Y. B., Kim, K., No, J. H., Suh, D. H., Chung, J.-B., & Eom, K.-Y. (2021). Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible. Radiation Oncology (London, England), 16(1), 148.
• 16. Gursel, S. B., Serarslan, A., Meydan, A. D., Okumus, N., & Yasayacak, T. (2020). A comparison of tandem ring and tandem ovoid treatment as a curative brachytherapy component for cervical cancer. Journal of Contemporary Brachytherapy, 12(2), 111–117.